SCIENTIFIC publications

  • Screening in Lung Cancer: The Latest Evidence

    Seijo LM (1), Trujillo JC (2), Zulueta JJ (3).

    (1) Clínica Universidad de Navarra, Madrid, España; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, CIBERES, Instituto de Salud Carlos III, España.
    (2) Hospital de la Santa Creu i Sant Pau, Barcelona, España; Coordinador Área de Oncología Torácica, SEPAR, España.
    (3) Clínica Universidad de Navarra, Pamplona, España.

    Archivos de Bronconeumología 13 JUNE 2019

  • Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers

    Carmona-Abellan M (1), Gabilondo I (2), Murueta-Goyena A (3), Khurana V (4), Tijero B (5), Luquin MR (6), Acera M (1), Del Pino R (1), Gardeazabal J (7), Martínez-Valbuena I (6), Sanchez-Pernaute R (8), Gómez-Esteban JC (9)

    (1) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain.
    (2) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain; Ikerbasque: The Basque Foundation for Science, Bilbao, Spain.
    (3) Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain.
    (4) Ann Romney Center for Neurologic Disease, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
    (5) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain.
    (6) Department of Neurology, Clínica Universitaria de Navarra, Universidad de Navarra, Pamplona, Spain.
    (7) Dermatology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain.
    (8) Andalusian Initiative for Advanced Therapies, Junta de Andalusia, Seville, Spain.
    (9) Neurodegenerative Diseases Group, Biocruces Bizkaia Health Research Institute, Cruces-Barakaldo, Bizkaia, Spain; Neurology Department, Cruces University Hospital, Cruces-Barakaldo, Bizkaia, Spain

    Parkinsonism Related Disorders 05 JUNE 2019

  • Drug-induced sleep endoscopy

    Carrasco Llatas M (1), Martínez Ruiz de Apodaca P (2), Baptista Jardín P (3), O'Connor Reina C (4), Plaza Mayor G (5), Méndez-Benegassi Silva I (6), Vicente González E (7), Vilaseca González I (8), Navazo Egía AI (9), Samará Piñol L (10), Álvarez García I (11), Vila Martín J (12), Esteller Moré E (13).

    (1) Servicio de ORL, Hospital Universitario Dr. Peset, Valencia, España.
    (2) Servicio de ORL, Hospital Universitario Dr. Peset, Valencia, España.
    (3) Departamento de ORL, Clínica Universidad de Navarra, Pamplona, España.
    (4) Servicio de ORL, Hospitales Quirón Salud Marbella y Campo de Gibraltar, Marbella, Málaga, España.
    (5) Servicio de ORL, Hospital Universitario de Fuenlabrada y Hospital Sanitas la Zarzuela, Universidad Rey Juan Carlos, Madrid, España.
    (6) Servicio de ORL, Hospital Rey Juan Carlos, Móstoles, Madrid, España.
    (7) Sección de ORL, Hospital Universitario Miguel Servet, Zaragoza, España.
    (8) Sección de ORL, Hospital Clínic, Universitat de Barcelona, Barcelona, España.
    (9) Servicio ORL, Hospital Universitario de Burgos, Burgos, España.
    (10) Servicio de ORL, Hospital Comarcal de l'Alt Penedès, Vilafranca del Penedès, Barcelona, España.
    (11) Servicio de ORL, Hospital Universitario Cruces, Barakaldo, Vizcaya, España.
    (12) Servicio de ORL, Hospital Universitari Vall d'Hebron, Barcelona, España.
    (13) Servicio ORL, Hospital General Universitario de Catalunya, Universitat Internacional de Catalunya, Sant Cugat del Vallès, Barcelona, España.

    Acta Otorrinolaringologica Española 04 JUNE 2019

  • The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models

    Martínez-Vélez N (1,2,3), Garcia-Moure M (1,2,3), Marigil M (1,2,3), González-Huarriz M (1,2,3), Puigdelloses M (1,2,4), Gallego Pérez-Larraya J (1,2,4), Zalacaín M (1,2,3), Marrodán L (1,2,3), Varela-Guruceaga M (1,2,3), Laspidea V (1,2,3), Aristu JJ (1,5), Ramos LI (1,5), Tejada-Solís S (1,6), Díez-Valle R (1,6), Jones C (7,8), Mackay A (7,8), Martínez-Climent JA (1,9), García-Barchino MJ (1,9), Raabe E (10,11), Monje M (12), Becher OJ (13), Junier MP (14), El-Habr EA (14), Chneiweiss H (14), Aldave G (15), Jiang H (16), Fueyo J (16,17), Patiño-García A (1,2,3), Gomez-Manzano C (18), Alonso MM (19,20,21).

    (1) Health Research Institute of Navarra (IDISNA), Pamplona, Navarra, Spain.
    (2) Program of Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Navarra, Pamplona, Spain.
    (3) Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.
    (4) Department of Neurology, Clínica Universidad de Navarra, Pamplona, Spain.
    (5) Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.
    (6) Department of Neurosurgery, Clínica Universidad de Navarra, Pamplona, Spain.
    (7) Division of Molecular Pathology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, Surrey, SM2 5NG, UK.
    (8) Division of Cancer Therapeutics, The Institute of Cancer Research, 15 Cotswold Road, Sutton, London, Surrey, SM2 5NG, UK.
    (9) Division of Hematopoietic Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, CIBERONC, Pamplona, Pamplona, Navarra, Spain.
    (10) Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    (11) Division of Pediatric Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
    (12) Department of Neurology, Stanford University School of Medicine, Stanford, CA, USA.
    (13) Department of Pediatrics, Northwestern University and Division of Pediatric Hematology-Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital, Chicago, IL, USA.
    (14) CNRS UMR8246, Inserm U1130, Neuroscience Paris Seine - IBPS, Sorbonne Universities, Paris, France.
    (15) Division of Pediatric Neurosurgery, Department of Surgery, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
    (16) Department of NeuroOncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    (17) Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    (18) Department of NeuroOncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
    (19) Health Research Institute of Navarra (IDISNA), Pamplona, Navarra, Spain.
    (20) Program of Solid Tumors, Center for the Applied Medical Research (CIMA), University of Navarra, Navarra, Pamplona, Spain.
    (21) Department of Pediatrics, Clínica Universidad de Navarra, Pamplona, Spain.

    Nature Communications 28 MAY 2019

  • Reduced Plasma Orexin-A Concentrations are Associated with Cognitive Deficits in Anorexia Nervosa

    Steward T (1,2), Mestre-Bach G (1,2), Granero R (2,3), Sánchez I (1,2), Riesco N (1,2), Vintró-Alcaraz C (1,2), Sauchelli S (1), Jiménez-Murcia S (1,2,4), Agüera Z (1,2), Fernández-García JC (2,5), Garrido-Sánchez L (2,5), Tinahones FJ (2,5), Casanueva FF (2,6), Baños RM (2,7), Botella C (2), Crujeiras AB (2,6), Torre R (2,8,9), Fernández-Real JM (2,10), Frühbeck G (2,11), Ortega FJ (2,10), Rodríguez A (2,11), Menchón JM (1,4,12), Fernández-Aranda F (13,14,15).

    (1) Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
    (2) Ciber Fisiopatologia Obesidad y Nutrición, Instituto Salud Carlos III (Spain), Madrid, Spain.
    (3) Departament de Psicobiologia i Metodologia, Universitat Autònoma de Barcelona, Barcelona, Spain.
    (4) Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain.
    (5) Unidad de Gestión Clínica de Endocrinología y Nutrición, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga, Hospital Clínico Virgen de la Victoria, Málaga, Spain.
    (6) Molecular and Celular Endocrinology, Instituto de Investigacion Sanitaria (IDIS), Complejo Hospitalario Universitario de Santiago (CHUS) and Santiago de Compostela University (USC), Santiago de Compostela, Spain.
    (7) Department of Psychological, Personality, Evaluation and Treatment of the University of Valencia, Valencia, Spain.
    (8) Integrated Pharmacology and Systems Neurosciences Research Group, Neuroscience Research Program Organization IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
    (9) Department of Health and Experimental Sciences, Universitat Pompeu Fabra Barcelona, Barcelona, Spain.
    (10) Department of Diabetes, Endocrinology and Nutrition, Institut d'Investigació, Biomèdica de Girona (IdIBGi), Hospital Dr Josep Trueta, Girona, Spain.
    (11) Metabolic Research Laboratory, Clínica Universidad de Navarra, University of Navarra-IdiSNA, Pamplona, Spain.
    (12) CIBER Salud Mental, Instituto Salud Carlos III (Spain), Madrid, Spain.
    (13) Department of Psychiatry, Bellvitge University Hospital-IDIBELL, Barcelona, Spain.
    (14) Ciber Fisiopatologia Obesidad y Nutrición, Instituto Salud Carlos III (Spain), Madrid, Spain.
    (15) Department of Clinical Sciences, School of Medicine, University of Barcelona, Barcelona, Spain.

    Scientific Reports 27 MAY 2019

you mayBE INTERESTED

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra